Premenstrual Dysphoric Disorder Market - Forecast(2019 - 2024)

Report Code: HCR 0266 Report Format: PDF + Excel (Delivery in 48 Hrs)
Premenstrual dysphoric disorder (PMDD) is a medical condition in which a woman undergoes severe depression symptoms, irritability, and tension before menstruation cycle. These symptoms of premenstrual dysphoric disorder are more severe than those seen with premenstrual syndrome (PMS). Some of the major factors playing important role for the PMDD are alcohol or substance abuse, thyroid disorders, being overweight, having a mother with a history of the disorder and lack of exercise. Some of the common symptoms of PMDD are anxiety, out of control feeling, food cravings or binge eating, mood swings with bouts of crying and panic attacks, bloating, breast tenderness, headaches, and joint or muscle pain, problems sleeping, trouble concentrating. Globally increasing awareness and registered cases of PMDD are expected to drive the demand for the PMDD market however regulations over the usage of such medicines in some of the nations  and higher R&D cost involved to develop new drugs and treatments is expected to be the key constraints during the period of study.

This report identifies the global premenstrual dysphoric disorder market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to premenstrual dysphoric disorder market.
 
Premenstrual Dysphoric Disorder Market

Geographically, North America dominated the premenstrual dysphoric disorder market due to higher awareness about such diseases, higher registered cases due to life style related health issues and well developed healthcare infrastructure. North America was followed by Europe and Asia-Pacific as the second and third largest consumer of premenstrual dysphoric disorder. Asia Pacific is projected to have the fastest growth, owing to rapidly expanding healthcare infrastructure, increasing awareness especially in the major regional economies such as India and China in the region. 

This report segments premenstrual dysphoric disorder market on the basis of clinical trial phase and regional market as follows:

  • On the basis of clinical trial phase this report on premenstrual dysphoric disorder market is segmented as follows, covering major segments as follows: Clinical Trial Phase 1, Clinical Trial Phase 2, Clinical Trial Phase 3, and commercially Launched
  • This report on premenstrual dysphoric disorder has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the premenstrual dysphoric disorder market. Some of the major companies’ profiles in detail are as follows:
  • Bristol Meyer Squibb
  • Merck and Co.
  • Novartis AG
  • Pfizer, Inc.
  • Cipla Laboratories.
1. Premenstrual Dysphoric Disorder Market - Overview
1.1. Definitions and Scope
2. Premenstrual Dysphoric Disorder Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Premenstrual Dysphoric Disorder Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Premenstrual Dysphoric Disorder Market – Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Premenstrual Dysphoric Disorder Market – Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Premenstrual Dysphoric Disorder Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Premenstrual Dysphoric Disorder Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Premenstrual Dysphoric Disorder Market – By Clinical Trial Phase (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Clinical Trial Phase 1
8.3.2. Clinical Trial Phase 2
8.3.3. Clinical Trial Phase 3
8.3.4. Commercially Launched
9. Premenstrual Dysphoric Disorder - By Geography (Market Size -$Million / $Billion)
9.1. Premenstrual Dysphoric Disorder Market - North America Segment Research
9.2. North America Market Research (Million / $Billion)
9.2.1. Segment type Size and Market Size Analysis 
9.2.2. Revenue and Trends
9.2.3. Application Revenue and Trends by type of Application
9.2.4. Company Revenue and Product Analysis
9.2.5. North America Product type and Application Market Size
9.2.5.1. U.S.
9.2.5.2. Canada 
9.2.5.3. Mexico 
9.2.5.4. Rest of North America
9.3. Premenstrual Dysphoric Disorder - South America Segment Research
9.4. South America Market Research (Market Size -$Million / $Billion)
9.4.1. Segment type Size and Market Size Analysis 
9.4.2. Revenue and Trends
9.4.3. Application Revenue and Trends by type of Application
9.4.4. Company Revenue and Product Analysis
9.4.5. South America Product type and Application Market Size
9.4.5.1. Brazil  
9.4.5.2. Venezuela
9.4.5.3. Argentina
9.4.5.4. Ecuador
9.4.5.5. Peru
9.4.5.6. Colombia 
9.4.5.7. Costa Rica
9.4.5.8. Rest of South America
9.5. Premenstrual Dysphoric Disorder - Europe Segment Research
9.6. Europe Market Research (Market Size -$Million / $Billion)
9.6.1. Segment type Size and Market Size Analysis 
9.6.2. Revenue and Trends
9.6.3. Application Revenue and Trends by type of Application
9.6.4. Company Revenue and Product Analysis
9.6.5. Europe Segment Product type and Application Market Size
9.6.5.1. U.K  
9.6.5.2. Germany 
9.6.5.3. Italy 
9.6.5.4. France
9.6.5.5. Netherlands
9.6.5.6. Belgium
9.6.5.7. Spain
9.6.5.8. Denmark
9.6.5.9. Rest of Europe
9.7. Premenstrual Dysphoric Disorder – APAC Segment Research
9.8. APAC Market Research (Market Size -$Million / $Billion)
9.8.1. Segment type Size and Market Size Analysis 
9.8.2. Revenue and Trends
9.8.3. Application Revenue and Trends by type of Application
9.8.4. Company Revenue and Product Analysis
9.8.5. APAC Segment – Product type and Application Market Size
9.8.5.1. China 
9.8.5.2. Australia
9.8.5.3. Japan 
9.8.5.4. South Korea
9.8.5.5. India
9.8.5.6. Taiwan
9.8.5.7. Malaysia
10. Premenstrual Dysphoric Disorder Market - Entropy
10.1. New product launches
10.2. M&A's, collaborations, JVs and partnerships
11. Premenstrual Dysphoric Disorder Market – Industry / Segment Competition landscape Premium
11.1. Market Share Analysis
11.1.1. Market Share by Country- Top companies
11.1.2. Market Share by Region- Top 10 companies
11.1.3. Market Share by type of Application – Top 10 companies
11.1.4. Market Share by type of Product / Product category- Top 10 companies
11.1.5. Market Share at global level- Top 10 companies
11.1.6. Best Practises for companies
12. Premenstrual Dysphoric Disorder Market – Key Company List by Country Premium
13. Premenstrual Dysphoric Disorder Market Company Analysis
13.1. Market Share, Company Revenue, Products, M&A, Developments
13.2. Bristol Meyer Squibb
13.3. Merck and Co.
13.4. Novartis AG
13.5. Pfizer, Inc.
13.6. Cipla Laboratories
13.7. GlaxoSmithKline plc
13.8. Johnson & Johnson
13.9. Abbott Healthcare
13.10. Eli Lilly and Company
13.11. Dr. Reddy’s Laboratories Ltd.
13.12. Company 11
13.13. Company 12
13.14. Company 13 and more
"*Financials would be provided on a best efforts basis for private companies"
14. Premenstrual Dysphoric Disorder Market - Appendix
14.1. Abbreviations
14.2. Sources
15. Premenstrual Dysphoric Disorder Market - Methodology
15.1. Research Methodology
15.1.1. Company Expert Interviews
15.1.2. Industry Databases
15.1.3. Associations
15.1.4. Company News
15.1.5. Company Annual Reports
15.1.6. Application Trends
15.1.7. New Products and Product database
15.1.8. Company Transcripts
15.1.9. R&D Trends
15.1.10. Key Opinion Leaders Interviews
15.1.11. Supply and Demand Trends
List of Tables
Table1 Premenstrual Dysphoric Disorder Market Overview 2019-2024
Table2 Premenstrual Dysphoric Disorder Market Leader Analysis 2018-2019 (US$)
Table3 Premenstrual Dysphoric Disorder MarketProduct Analysis 2018-2019 (US$)
Table4 Premenstrual Dysphoric Disorder MarketEnd User Analysis 2018-2019 (US$)
Table5 Premenstrual Dysphoric Disorder MarketPatent Analysis 2013-2018* (US$)
Table6 Premenstrual Dysphoric Disorder MarketFinancial Analysis 2018-2019 (US$)
Table7 Premenstrual Dysphoric Disorder Market Driver Analysis 2018-2019 (US$)
Table8 Premenstrual Dysphoric Disorder MarketChallenges Analysis 2018-2019 (US$)
Table9 Premenstrual Dysphoric Disorder MarketConstraint Analysis 2018-2019 (US$)
Table10 Premenstrual Dysphoric Disorder Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table11 Premenstrual Dysphoric Disorder Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table12 Premenstrual Dysphoric Disorder Market Threat of Substitutes Analysis 2018-2019 (US$)
Table13 Premenstrual Dysphoric Disorder Market Threat of New Entrants Analysis 2018-2019 (US$)
Table14 Premenstrual Dysphoric Disorder Market Degree of Competition Analysis 2018-2019 (US$)
Table15 Premenstrual Dysphoric Disorder MarketValue Chain Analysis 2018-2019 (US$)
Table16 Premenstrual Dysphoric Disorder MarketPricing Analysis 2019-2024 (US$)
Table17 Premenstrual Dysphoric Disorder MarketOpportunities Analysis 2019-2024 (US$)
Table18 Premenstrual Dysphoric Disorder MarketProduct Life Cycle Analysis 2019-2024 (US$)
Table19 Premenstrual Dysphoric Disorder MarketSupplier Analysis 2018-2019 (US$)
Table20 Premenstrual Dysphoric Disorder MarketDistributor Analysis 2018-2019 (US$)
Table21 Premenstrual Dysphoric Disorder Market Trend Analysis 2018-2019 (US$)
Table22 Premenstrual Dysphoric Disorder Market Size 2018 (US$)
Table23 Premenstrual Dysphoric Disorder Market Forecast Analysis 2019-2024 (US$)
Table24 Premenstrual Dysphoric Disorder Market Sales Forecast Analysis 2019-2024 (Units)
Table25 Premenstrual Dysphoric Disorder Market, Revenue & Volume,By Clinical Trial Phase, 2019-2024 ($)
Table26 Premenstrual Dysphoric Disorder MarketBy Clinical Trial Phase, Revenue & Volume,By Clinical Trial Phase 1, 2019-2024 ($)
Table27 Premenstrual Dysphoric Disorder MarketBy Clinical Trial Phase, Revenue & Volume,By Clinical Trial Phase 2, 2019-2024 ($)
Table28 Premenstrual Dysphoric Disorder MarketBy Clinical Trial Phase, Revenue & Volume,By Clinical Trial Phase 3, 2019-2024 ($)
Table29 Premenstrual Dysphoric Disorder MarketBy Clinical Trial Phase, Revenue & Volume,By Commercially Launched, 2019-2024 ($)
Table30 North America Premenstrual Dysphoric Disorder Market, Revenue & Volume,By Clinical Trial Phase, 2019-2024 ($)
Table31 South america Premenstrual Dysphoric Disorder Market, Revenue & Volume,By Clinical Trial Phase, 2019-2024 ($)
Table32 Europe Premenstrual Dysphoric Disorder Market, Revenue & Volume,By Clinical Trial Phase, 2019-2024 ($)
Table33 APAC Premenstrual Dysphoric Disorder Market, Revenue & Volume,By Clinical Trial Phase, 2019-2024 ($)
Table34 Middle East & Africa Premenstrual Dysphoric Disorder Market, Revenue & Volume,By Clinical Trial Phase, 2019-2024 ($)
Table35 Russia Premenstrual Dysphoric Disorder Market, Revenue & Volume,By Clinical Trial Phase, 2019-2024 ($)
Table36 Israel Premenstrual Dysphoric Disorder Market, Revenue & Volume,By Clinical Trial Phase, 2019-2024 ($)
Table37 Top Companies 2018 (US$)Premenstrual Dysphoric Disorder Market, Revenue & Volume,,
Table38 Product Launch 2018-2019Premenstrual Dysphoric Disorder Market, Revenue & Volume,,
Table39 Mergers & Acquistions 2018-2019Premenstrual Dysphoric Disorder Market, Revenue & Volume,,

List of Figures
Figure 1 Overview of Premenstrual Dysphoric Disorder Market 2019-2024
Figure 2 Market Share Analysis for Premenstrual Dysphoric Disorder Market 2018 (US$)
Figure 3 Product Comparison in Premenstrual Dysphoric Disorder Market 2018-2019 (US$)
Figure 4 End User Profile for Premenstrual Dysphoric Disorder Market 2018-2019 (US$)
Figure 5 Patent Application and Grant in Premenstrual Dysphoric Disorder Market 2013-2018* (US$)
Figure 6 Top 5 Companies Financial Analysis in Premenstrual Dysphoric Disorder Market 2018-2019 (US$)
Figure 7 Market Entry Strategy in Premenstrual Dysphoric Disorder Market 2018-2019
Figure 8 Ecosystem Analysis in Premenstrual Dysphoric Disorder Market2018
Figure 9 Average Selling Price in Premenstrual Dysphoric Disorder Market 2019-2024
Figure 10 Top Opportunites in Premenstrual Dysphoric Disorder Market 2018-2019
Figure 11 Market Life Cycle Analysis in Premenstrual Dysphoric Disorder Market
Figure 12 GlobalBy Clinical Trial PhasePremenstrual Dysphoric Disorder Market Revenue, 2019-2024 ($)
Figure 13 Global Premenstrual Dysphoric Disorder Market - By Geography
Figure 14 Global Premenstrual Dysphoric Disorder Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 15 Global Premenstrual Dysphoric Disorder Market CAGR, By Geography, 2019-2024 (%)
Figure 16 North America Premenstrual Dysphoric Disorder Market Value & Volume, 2019-2024 ($)
Figure 17 US Premenstrual Dysphoric Disorder Market Value & Volume, 2019-2024 ($)
Figure 18 US GDP and Population, 2018-2019 ($)
Figure 19 US GDP – Composition of 2018, By Sector of Origin
Figure 20 US Export and Import Value & Volume, 2018-2019 ($)
Figure 21 Canada Premenstrual Dysphoric Disorder Market Value & Volume, 2019-2024 ($)
Figure 22 Canada GDP and Population, 2018-2019 ($)
Figure 23 Canada GDP – Composition of 2018, By Sector of Origin
Figure 24 Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 25 Mexico Premenstrual Dysphoric Disorder Market Value & Volume, 2019-2024 ($)
Figure 26 Mexico GDP and Population, 2018-2019 ($)
Figure 27 Mexico GDP – Composition of 2018, By Sector of Origin
Figure 28 Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 29 South America Premenstrual Dysphoric Disorder MarketSouth America 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 30 Brazil Premenstrual Dysphoric Disorder Market Value & Volume, 2019-2024 ($)
Figure 31 Brazil GDP and Population, 2018-2019 ($)
Figure 32 Brazil GDP – Composition of 2018, By Sector of Origin
Figure 33 Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 34 Venezuela Premenstrual Dysphoric Disorder Market Value & Volume, 2019-2024 ($)
Figure 35 Venezuela GDP and Population, 2018-2019 ($)
Figure 36 Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 37 Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 38 Argentina Premenstrual Dysphoric Disorder Market Value & Volume, 2019-2024 ($)
Figure 39 Argentina GDP and Population, 2018-2019 ($)
Figure 40 Argentina GDP – Composition of 2018, By Sector of Origin
Figure 41 Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 42 Ecuador Premenstrual Dysphoric Disorder Market Value & Volume, 2019-2024 ($)
Figure 43 Ecuador GDP and Population, 2018-2019 ($)
Figure 44 Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 45 Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 46 Peru Premenstrual Dysphoric Disorder Market Value & Volume, 2019-2024 ($)
Figure 47 Peru GDP and Population, 2018-2019 ($)
Figure 48 Peru GDP – Composition of 2018, By Sector of Origin
Figure 49 Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 50 Colombia Premenstrual Dysphoric Disorder Market Value & Volume, 2019-2024 ($)
Figure 51 Colombia GDP and Population, 2018-2019 ($)
Figure 52 Colombia GDP – Composition of 2018, By Sector of Origin
Figure 53 Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 54 Costa Rica Premenstrual Dysphoric Disorder MarketCosta Rica 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 55 Costa Rica GDP and Population, 2018-2019 ($)
Figure 56 Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 57 Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 58 Europe Premenstrual Dysphoric Disorder Market Value & Volume, 2019-2024 ($)
Figure 59 U.K Premenstrual Dysphoric Disorder Market Value & Volume, 2019-2024 ($)
Figure 60 U.K GDP and Population, 2018-2019 ($)
Figure 61 U.K GDP – Composition of 2018, By Sector of Origin
Figure 62 U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 63 Germany Premenstrual Dysphoric Disorder Market Value & Volume, 2019-2024 ($)
Figure 64 Germany GDP and Population, 2018-2019 ($)
Figure 65 Germany GDP – Composition of 2018, By Sector of Origin
Figure 66 Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 67 Italy Premenstrual Dysphoric Disorder Market Value & Volume, 2019-2024 ($)
Figure 68 Italy GDP and Population, 2018-2019 ($)
Figure 69 Italy GDP – Composition of 2018, By Sector of Origin
Figure 70 Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 71 France Premenstrual Dysphoric Disorder Market Value & Volume, 2019-2024 ($)
Figure 72 France GDP and Population, 2018-2019 ($)
Figure 73 France GDP – Composition of 2018, By Sector of Origin
Figure 74 France Export and Import Value & Volume, 2018-2019 ($)
Figure 75 Netherlands Premenstrual Dysphoric Disorder Market Value & Volume, 2019-2024 ($)
Figure 76 Netherlands GDP and Population, 2018-2019 ($)
Figure 77 Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 78 Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 79 Belgium Premenstrual Dysphoric Disorder Market Value & Volume, 2019-2024 ($)
Figure 80 Belgium GDP and Population, 2018-2019 ($)
Figure 81 Belgium GDP – Composition of 2018, By Sector of Origin
Figure 82 Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 83 Spain Premenstrual Dysphoric Disorder Market Value & Volume, 2019-2024 ($)
Figure 84 Spain GDP and Population, 2018-2019 ($)
Figure 85 Spain GDP – Composition of 2018, By Sector of Origin
Figure 86 Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 87 Denmark Premenstrual Dysphoric Disorder Market Value & Volume, 2019-2024 ($)
Figure 88 Denmark GDP and Population, 2018-2019 ($)
Figure 89 Denmark GDP – Composition of 2018, By Sector of Origin
Figure 90 Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 91 APAC Premenstrual Dysphoric Disorder Market Value & Volume, 2019-2024 ($)
Figure 92 China Premenstrual Dysphoric Disorder MarketValue & Volume, 2019-2024
Figure 93 China GDP and Population, 2018-2019 ($)
Figure 94 China GDP – Composition of 2018, By Sector of Origin
Figure 95 China Export and Import Value & Volume, 2018-2019 ($)Premenstrual Dysphoric Disorder MarketChina Export and Import Value & Volume, 2018-2019 ($)
Figure 96 Australia Premenstrual Dysphoric Disorder Market Value & Volume, 2019-2024 ($)
Figure 97 Australia GDP and Population, 2018-2019 ($)
Figure 98 Australia GDP – Composition of 2018, By Sector of Origin
Figure 99 Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 100 South Korea Premenstrual Dysphoric Disorder Market Value & Volume, 2019-2024 ($)
Figure 101 South Korea GDP and Population, 2018-2019 ($)
Figure 102 South Korea GDP – Composition of 2018, By Sector of Origin
Figure 103 South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 104 India Premenstrual Dysphoric Disorder Market Value & Volume, 2019-2024 ($)
Figure 105 India GDP and Population, 2018-2019 ($)
Figure 106 India GDP – Composition of 2018, By Sector of Origin
Figure 107 India Export and Import Value & Volume, 2018-2019 ($)
Figure 108 Taiwan Premenstrual Dysphoric Disorder MarketTaiwan 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 109 Taiwan GDP and Population, 2018-2019 ($)
Figure 110 Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 111 Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 112 Malaysia Premenstrual Dysphoric Disorder MarketMalaysia 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 113 Malaysia GDP and Population, 2018-2019 ($)
Figure 114 Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 115 Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 116 Hong Kong Premenstrual Dysphoric Disorder MarketHong Kong 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 117 Hong Kong GDP and Population, 2018-2019 ($)
Figure 118 Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 119 Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 120 Middle East & Africa Premenstrual Dysphoric Disorder MarketMiddle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 121 Russia Premenstrual Dysphoric Disorder MarketRussia 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 122 Russia GDP and Population, 2018-2019 ($)
Figure 123 Russia GDP – Composition of 2018, By Sector of Origin
Figure 124 Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 125 Israel Premenstrual Dysphoric Disorder Market Value & Volume, 2019-2024 ($)
Figure 126 Israel GDP and Population, 2018-2019 ($)
Figure 127 Israel GDP – Composition of 2018, By Sector of Origin
Figure 128 Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 129 Entropy Share, By Strategies, 2018-2019* (%)Premenstrual Dysphoric Disorder Market
Figure 130 Developments, 2018-2019*Premenstrual Dysphoric Disorder Market
Figure 131 Company 1 Premenstrual Dysphoric Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 132 Company 1 Premenstrual Dysphoric Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 133 Company 1 Premenstrual Dysphoric Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 134 Company 2 Premenstrual Dysphoric Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 135 Company 2 Premenstrual Dysphoric Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 136 Company 2 Premenstrual Dysphoric Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 137 Company 3Premenstrual Dysphoric Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 138 Company 3Premenstrual Dysphoric Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 139 Company 3Premenstrual Dysphoric Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 140 Company 4 Premenstrual Dysphoric Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 141 Company 4 Premenstrual Dysphoric Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 142 Company 4 Premenstrual Dysphoric Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 143 Company 5 Premenstrual Dysphoric Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 144 Company 5 Premenstrual Dysphoric Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 145 Company 5 Premenstrual Dysphoric Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 146 Company 6 Premenstrual Dysphoric Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 147 Company 6 Premenstrual Dysphoric Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 148 Company 6 Premenstrual Dysphoric Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 149 Company 7 Premenstrual Dysphoric Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 150 Company 7 Premenstrual Dysphoric Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 151 Company 7 Premenstrual Dysphoric Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 152 Company 8 Premenstrual Dysphoric Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 153 Company 8 Premenstrual Dysphoric Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 154 Company 8 Premenstrual Dysphoric Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 155 Company 9 Premenstrual Dysphoric Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 156 Company 9 Premenstrual Dysphoric Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 157 Company 9 Premenstrual Dysphoric Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 158 Company 10 Premenstrual Dysphoric Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 159 Company 10 Premenstrual Dysphoric Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 160 Company 10 Premenstrual Dysphoric Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 161 Company 11 Premenstrual Dysphoric Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 162 Company 11 Premenstrual Dysphoric Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 163 Company 11 Premenstrual Dysphoric Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 164 Company 12 Premenstrual Dysphoric Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 165 Company 12 Premenstrual Dysphoric Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 166 Company 12 Premenstrual Dysphoric Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 167 Company 13Premenstrual Dysphoric Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 168 Company 13Premenstrual Dysphoric Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 169 Company 13Premenstrual Dysphoric Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 170 Company 14 Premenstrual Dysphoric Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 171 Company 14 Premenstrual Dysphoric Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 172 Company 14 Premenstrual Dysphoric Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 173 Company 15 Premenstrual Dysphoric Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 174 Company 15 Premenstrual Dysphoric Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 175 Company 15 Premenstrual Dysphoric Disorder Market Net Sales Share, By Geography, 2018 (%)